End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
770,000 KRW | -1.28% | -2.53% | +1.32% |
Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
Apr. 25 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.32% | 40.42B | |
-4.66% | 87.53B | |
-19.55% | 29.48B | |
+57.86% | 25.43B | |
-17.79% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B | |
+1.73% | 7.67B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics' Net Income Surges 141% in March Quarter